Critical care has reached an interesting crossroads.
We have more guidelines than ever before. We have more evidence, more technology, more monitoring, more therapeutic options and, increasingly, more algorithms telling us what we should do.And yet, anyone who has spent enough years inside an ICU knows one uncomfortable truth:The difficult part of critical care is rarely knowing the guideline. The difficult part is knowing what to do when the patient in front of you does not behave like the guideline.

That, to me, is where Mumbai ISCCM has an enormous opportunity.

My vision is to make our academic platform increasingly focused on real-world practice—the space where evidence meets uncertainty, physiology meets logistics, and recommendations have to survive the realities of an ICU at 2 a.m.
I would like Mumbai ISCCM to become a forum where we move beyond simply asking, “What does the literature say?” and begin asking, “What exactly will I do for this patient tomorrow morning?”
From lectures to clinical conversationsThe conventional lecture will always have a place in medicine. We need experts to teach us what has changed, what the trials show and what the guidelines recommend.But learning becomes far more powerful when the audience is forced to make a decision.

Consider a patient with septic shock on increasing norepinephrine, worsening lactate, bilateral infiltrates and a collapsing blood pressure. Do we give more fluid? Which fluid? How much? Do we perform a passive leg raise? What if the patient is ventilated with high PEEP? What does the echocardiogram show? At what point do we start vasopressin? When does hydrocortisone enter the conversation?There may be no single slide that answers all these questions.
This is where case-based discussions become invaluable.Rather than presenting the final diagnosis and management, we should reveal the case sequentially. Allow the audience and panel to make decisions at each stage. Then introduce the next piece of information.

The purpose is not merely to find the “correct answer.” It is to expose the reasoning.
Why did you choose that intervention? What physiological problem are you trying to correct? What evidence supports it? What could go wrong? What would make you change your mind?That is how experienced clinicians actually practise medicine.Debates should illuminate the grey zones.Critical care is full of areas where intelligent clinicians can look at the same evidence and reasonably practise differently.Early versus delayed renal replacement therapy. Liberal versus restrictive fluids. High versus moderate protein delivery. NIV versus early intubation. Recruitment manoeuvres. Corticosteroids. Albumin. Anticoagulation strategies. Duration of antibiotics. Tracheostomy timing.These discussions should not become theatrical arguments where one side must “win.”
A good debate should make the audience slightly uncomfortable about the certainty with which they held their original position.
The debater should be asked not merely to defend a position, but to define the patient in whom that position is likely to work—and the patient in whom it could be harmful.That is where nuance enters medicine.
I would therefore like our debates to end with an important question:“After hearing both sides, what will you actually do differently in your ICU?”Because education without a change in behaviour is interesting—but implementation is what ultimately changes outcomes.

Panels must move beyond expert opinion.Panel discussions are extraordinarily valuable when structured properly.
Instead of asking broad questions such as “How do you manage ARDS?”, we should present precise dilemmas.
A patient with severe ARDS is on PEEP 14 cm H₂O, plateau pressure 28, driving pressure 15 and worsening oxygenation. Would you prone? Would you recruit? Would you increase PEEP? Would you measure oesophageal pressure? Would you consider ECMO?
Now the panel becomes meaningful.Different experts may choose different approaches, but each must explain the physiological and evidentiary basis for that decision.

Importantly, panels should include the practical barriers we face in India.What if ECMO is unavailable?
What if the patient cannot afford repeated molecular diagnostics?What if a dietitian is not available round the clock?What if nurse-to-patient ratios are constrained?What if the latest recommended antimicrobial is unavailable or unaffordable?Indian critical care cannot simply be a transcription of Western guidelines. We need to interpret global evidence through the realities of Indian intensive care.Mumbai, with its extraordinary diversity of public hospitals, teaching institutions, corporate hospitals and nursing homes, is perhaps one of the best laboratories in the country for these conversations.

The implementation conversationOne area I feel especially strongly about is implementation.
We frequently attend excellent conferences, return inspired—and by Monday morning, very little has changed.Therefore, after important sessions, I would like us to ask:How will we implement this?If we agree that malnutrition and muscle loss matter, do our ICUs actually measure nutritional risk, protein delivery and muscle function?If antimicrobial stewardship is important, who reviews antibiotics at 48–72 hours?If lung-protective ventilation saves lives, are tidal volumes and driving pressures being audited?If delirium prevention matters, are we measuring it?If early mobilisation works, who owns the process?This is where Mumbai ISCCM can move from being purely an academic organisation to becoming a clinical improvement community.Sessions can conclude with simple implementation tools—checklists, algorithms, bedside protocols, audit parameters and measurable targets.Three months later, centres can return and tell us what happened.

Not just, “We learnt this.”But-We implemented it.”
“Here were the barriers.”
“Here is what changed.”
That conversation could be transformational.Bringing the multidisciplinary ICU into the room.Modern intensive care is not delivered by the intensivist alone.Nurses, physiotherapists, dietitians, pharmacists, microbiologists, respiratory therapists and technicians influence outcomes every single day.Our real-world sessions should therefore increasingly represent the entire ICU ecosystem.
Imagine a difficult ventilator-weanng case discussed simultaneously by an intensivist, respiratory therapist, physiotherapist and nurse.Or an ICU nutrition case where the intensivist, dietitian and rehabilitation specialist examine the same patient from different perspectives.That is how care is actually delivered.Learning from failure.We must also create a culture where we can discus cases that did not go well.Not morbidity meetings designed to assign blame, but cognitive autopsies.Where did our reasoning fail?
Was there premature closure?Did we anchor on the first diagnosis?Did we continue fluids because the blood pressure was low without asking whether the patient was fluid responsive?
Did we escalate antibiotics when the real problem was source control?Some of our greatest lessons come from patients we could not save.A mature academic community must be able to discuss those cases with humility.

My vision

Ultimately, my vision for Mumbai ISCCM is simple.I want someone attending one of our meetings to walk into the ICU the following morning and practise slightly better medicine.I want the young intensivist to learn how experts think.I want the experienced intensivist to have belief challenged.I want the nurse to feel part of the scientific conversationI want evidece to meet physiology.
I want guidelines to meet reality. And I want our discussions to end not merely with applause, but with a question every clinician carries back to the bedside: “What am I going to do differently for my next patient?” If Mumbai ISCCM can repeatedly create that moment, we will have achieved something far more important than organising excellent academic programmes.
We will have created a culture of thinking, questioning, implementing and continuously improving critical care.
And that, in my view, is where a professional society creates its greatest impact.